Past CureTalks
Myeloma: 2016 Year in Review and Outlook for 2017
The treatment options for myeloma continued to evolve in 2016 with new agents, immune based therapies and repurposing of existing approved agents. High-dose therapy and autologous stem cell transplantation remain the backbone of upfront treatment in myeloma. We are talking…
Social Egg Freezing, All You Should Know
Social egg freezing less commonly known as non-medical egg freezing is being increasingly seen as a secure way of delaying childbearing by more and more women, especially in the US. But is it safe for all women? Who should be…
Focal Laser Ablation in Treatment of Localized Prostate Cancer – A Developing Therapeutic Option
MRI-guided focal laser ablation of the prostate is a developing treatment option for patients with localized prostate cancer. We are talking to Dr. Ara Karamanian on this new treatment technique and its nuances. The panel discussion will include a brief…
Post-Transplant Outcomes in High Risk Multiple Myeloma
Treatment of patients with myeloma has changed dramatically in the past years due to development of new agents and myeloma specific targets. Despite these advancements, long term benefits remains less clear in high-risk multiple myeloma patients. Myeloma is classified as…
Multidisciplinary Care of Melanoma (Skin Cancer)
No one knows your skin better than you do and you will be the first to notice any changes happening to it. Melanoma is one of the most common cancers in the US. Our Melanoma panel led by David Stanley…